Treatment Delay and HPV Status on OPSCC With Upfront Surgery: Analysis of National Cancer Database
Otolaryngology–Head and Neck Surgery · 2024
DOI: 10.1002/ohn.699 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Otolaryngology–Head and Neck Surgery, 2024. Verfasst von Milind Vasudev und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, University of California, Irvine, Orange, California, USA. Hauptthemen laut MEDLINE: Oropharyngeal Neoplasms, Papillomavirus Infections, Time-to-Treatment, Databases, Factual. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
Objective
Evaluate the effect of treatment delay on survival in human papillomavirus (HPV)‐positive and HPV‐negative oropharyngeal squamous cell carcinoma (OPSCC) patients undergoing primary surgical resection. Study Design Retrospective cohort study using the 2010‐2017 National Cancer Database.
Setting
Multicenter database study.
Methods
Patients >18 years old with OPSCC and known HPV status, treated surgically with or without postoperative radiation/chemotherapy were included. Two cohorts based on HPV status were grouped by time to treatment initiation (T D‐TI , ≤30, 31‐60, ≥61 days) and surgery to radiotherapy (T S‐RT , ≤42, 43‐66, ≥67 days). Univariate, Kaplan‐Meier, and multivariate analyses assessed correlations between demographic and clinical factors with overall survival in treatment delay groups.
Results
Included were 1643 HPV‐positive OPSCC patients and 391 HPV‐negative OPSCC patients. No associations between survival and gender, age, race, insurance, or radiotherapy length were observed. Regardless of HPV status, larger tumor size (>2 cm) and lymphovascular invasion predicted worse survival. HPV negative patients with >4 lymph nodes involved had 2.5× greater mortality risk ( P = .039). Robotic surgery was associated with improved survival only in HPV positive patients (hazard ratio [HR]: 0.41, P < .001). In HPV positive patients, higher T D‐TI related to lower mean survival, although this was not significant on multivariate analysis. HPV negative patients with >42 days of T S‐RT had decreased survival (43‐66 days, HR 1.63, P = .049; ≥67 days, HR 2.10, P = .032).
Conclusion
Longer T S‐RT was associated with lower overall survival in HPV negative patients. Treatment delay was not associated with survival in HPV positive OPSCC according to multivariate analysis. These findings enhance knowledge about treatment delay effects in OPSCC, aiding providers in decisions and patient communication.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, University of California, Irvine, Orange, California, USA.
- School of Medicine, University of California, San Diego, La Jolla, California, USA.
ORCID-Profile: Milind Vasudev
Zitieren
APA
Vasudev, M., Martin, E., Frank, M. I., Meller, L. L. T., & Haidar, Y. M. (2024). Treatment Delay and HPV Status on OPSCC With Upfront Surgery: Analysis of National Cancer Database. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.699
Vancouver
Vasudev M, Martin E, Frank MI, Meller LLT, Haidar YM. Treatment Delay and HPV Status on OPSCC With Upfront Surgery: Analysis of National Cancer Database. Otolaryngology–Head and Neck Surgery. 2024. doi:10.1002/ohn.699
BibTeX
@article{Vasudev2024,
author = {Vasudev, Milind and Martin, Elaine and Frank, Madelyn I and Meller, Leo L T and Haidar, Yarah M},
title = {Treatment Delay and HPV Status on OPSCC With Upfront Surgery: Analysis of National Cancer Database},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2024},
doi = {10.1002/ohn.699}
}
EUVIMED